© 2013 Dr. Paul A. Foster. Proudly made by Wix.com

  • facebook-square
  • Twitter Square
  • LinkedIn Square
Please reload

Follow Us

July 26, 2015

Prostate cancer is driven by androgens, particularly 5alpha-dihydrotestosterone (5alpha-DHT). Therapeutic options include systemic androgen deprivation therapy to limit 5alpha-DHT availability. However, many prostate tumours develop resistance to this line of therapy a...

Please reload

  • Facebook Classic
  • Twitter Classic
  • Google Classic
Please reload

Recent Posts
Search By Tags
Featured Posts

Anti-oestrogens inhibit colorectal tumourigenesis

January 28, 2014

Please reload